Imperial College London
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Asthma
FollowWhat is new in Asthma research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- 10,000 MG01 + 10,000 T517Phase 3 · NCT04891237
- 10,000 MG01 +10,000 T521Phase 3 · NCT04898283
- 10,000 MM09Phase 3 · NCT04435990
- 30,000 MG01 + 10,000 T517Phase 3 · NCT04891237
- 30,000 MG01 +10,000 T521Phase 3 · NCT04898283
- 30,000 MM09Phase 3 · NCT04435990
- 610Phase 3 · NCT06323213 · NCT06680947
- ABSPhase 3 · NCT06664619
- AcarizaxPhase 3 · NCT07013123
- Albuterol sulfatePhase 3 · NCT06052267
- Albuterol sulfate metered dose inhaler, MDIPhase 3 · NCT06471257
- Albuterol/budesonide (AIRSUPRA®)Phase 3 · NCT06473779
- Allergen Immunotherapy ExtractPhase 3 · NCT07348302
- AS MDIPhase 3 · NCT06307665
- BDA MDIPhase 3 · NCT06307665
- Beclometasone Dipropionate and Formoterol Inhalation AerosolPhase 3 · NCT07768891
- BenralizumabPhase 3 · NCT05692180 · NCT07444567 · NCT03010436
- BudesonidePhase 3 · NCT05562466
- Budesonide FormoterolPhase 3 · NCT06895460
- Budesonide/Albuterol metered dose inhaler, MDIPhase 3 · NCT06471257
- Budesonide/formoterolPhase 3 · NCT06473779 · NCT06429475 · NCT06676319
- Budesonide/Formoterol fumarate dihydratePhase 3 · NCT05831566
- CHF5993 100/6/12.5 μg pMDI HFA-152aPhase 3 · NCT07858123
- CM326Phase 3 · NCT07372287
- ComparatorPhase 3 · NCT07168473
- DepemokimabPhase 3 · NCT06979323 · NCT07456033 · NCT07671001
- Dexpramipexole DihydrochloridePhase 3 · NCT05748600
- DupilumabPhase 3 · NCT06191315 · NCT05347771 · NCT05575037 · NCT05720325
- Dupilumab Prefilled SyringePhase 3 · NCT07309614
- ELLIPTAPhase 3 · NCT05757102
- EP-088_MM09Phase 3 · NCT07904195 · NCT07904052
- EpiCeramPhase 3 · NCT03667651
- ExperimentalPhase 3 · NCT07168473
- Experimental: Participant Group CHF 5993 pMDI HFA-152aPhase 3 · NCT07546981
- FF/UMEC/VIPhase 3 · NCT05757102 · NCT04651777
- FF/VIPhase 3 · NCT05757102
- FOSTER®Phase 3 · NCT07768891
- FPPhase 3 · NCT06664619
- Fp/ABSPhase 3 · NCT06664619
- GB-0895Phase 3 · NCT07359846 · NCT07276724
- GSK5784283Phase 3 · NCT07780643 · NCT07712393 · NCT06748053 · NCT07782996
- HFA-134aPhase 3 · NCT07645248
- HFA-152aPhase 3 · NCT07645248
- HR-1703Phase 3 · NCT06653322
- Immune Modulators (Staphylococcus and Neisseria Tablets)Phase 3 · NCT06895460
- Magnesium sulfatePhase 3 · NCT06955559 · NCT06785272
- MannitolPhase 3 · NCT06473779
- MetfominPhase 3 · NCT07622290
- MG-K10/PlaceboPhase 3 · NCT06837922
- Normal SalinePhase 3 · NCT06785272
- QMF149Phase 3 · NCT05562466
- QVM149Phase 3 · NCT05776927
- SalbutamolPhase 3 · NCT06473779
- Salmeterol Xinafoate / Fluticasone PropionatePhase 3 · NCT05776927
- Seretide EvohalerPhase 3 · NCT07858123
- SHR-1905 InjectionPhase 3 · NCT07098403
- SHR-1905 Placebo InjectionPhase 3 · NCT07098403
- SIM0718 injectionPhase 3 · NCT06488755
- SIM0718 injection of placeboPhase 3 · NCT06488755
- TEV-56248Phase 3 · NCT06052267
- TezepelumabPhase 3 · NCT06473779 · NCT07013123 · NCT07363642 · NCT06189742 · NCT06740045 · NCT06023589
- tezepelumab (Arm1&Arm2)Phase 3 · NCT07302516
- tilrekimigPhase 3 · NCT07772921 · NCT07869043
- TQC2731 injectionPhase 3 · NCT06829784
- 3,000 MM09Phase 2/3 · NCT05641272
- 9,000 MM09Phase 2/3 · NCT05641272
- AzithromycinPhase 2/3 · NCT01233297 · NCT06223828
- CM310Phase 2/3 · NCT05761028
- DeflazacortPhase 2/3 · NCT04227483
- ICS+LABAPhase 2/3 · NCT06721247
- LevofloxacinPhase 2/3 · NCT06859450
- MagnesiumPhase 2/3 · NCT06721247
- PrednisolonePhase 2/3 · NCT04227483
- 5-HydroxytryptophanPhase 2 · NCT04160910
- AD17002Phase 2 · NCT07250594
- AK139Phase 2 · NCT07436221
- Amitriptyline 25 MGPhase 2 · NCT05110144
- Amitriptyline 50 MGPhase 2 · NCT05110144
- ARO-RAGEPhase 2 · NCT07241546
- Azithromycin Oral Liquid ProductPhase 2 · NCT05028153
- Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDIPhase 2 · NCT07282886
- BFF MDIPhase 2 · NCT07525375
- BrenipatidePhase 2 · NCT07219173
- Budesonide inhalantPhase 2 · NCT06940700
- Budesonide/AlbuterolPhase 2 · NCT06676319
- CHF5993 pMDI with HFA-134aPhase 2 · NCT07301736
- CHF5993 pMDI with HFA-152aPhase 2 · NCT07301736
- CHF718 pMDI with HFA-134aPhase 2 · NCT07301736
- CM512 injectionPhase 2 · NCT07011524
- CXA-10Phase 2 · NCT03762395
- Dexamethasone (0.25 mg/kg/dose, Max dose 16mg) every 6-hoursPhase 2 · NCT07455396
- Dexamethasone (0.6mg/kg; Max 16mg) Once DailyPhase 2 · NCT07455396
- Duloxetine 30 MGPhase 2 · NCT05110144
- Duloxetine 60 MGPhase 2 · NCT05110144
- ENV-294Phase 2 · NCT07301255
- EscitalopramPhase 2 · NCT06216535
- FB825Phase 2 · NCT05008965
- Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation PowderPhase 2 · NCT07282886
- Fluticasone Propionate Inhaled Aerosol 200 μg per day for 28 daysPhase 2 · NCT07324707
- Fluticasone/SalmeterolPhase 2 · NCT06676319
- FrevecitinibPhase 2 · NCT07532265
- Ginger ExtractPhase 2 · NCT07792395
- Glycopyrronium bromide 12.5ugPhase 2 · NCT05222529
- Glycopyrronium bromide 25ugPhase 2 · NCT05222529
- GP MDIPhase 2 · NCT07525375
- HSK31858Phase 2 · NCT06820749
- ICS-LABAPhase 2 · NCT05851443
- InulinPhase 2 · NCT06372249
- JNJ-95597528Phase 2 · NCT07746687
- Ketamine (1 mg/kg)Phase 2 · NCT07728851
- KT-621Phase 2 · NCT07677059 · NCT07323654
- L-citrullinePhase 2 · NCT05259904
- L-ctirullinePhase 2 · NCT03885245
- L-mentholPhase 2 · NCT07500974
- linvemastatPhase 2 · NCT07191535
- LP-003 InjectionPhase 2 · NCT07342803
- LQ036Phase 2 · NCT07589439
- Lung Clearance IndexPhase 2 · NCT02740868
- LunsekimigPhase 2 · NCT06609239 · NCT06676319
- Magnetic Resonance ImagingPhase 2 · NCT02740868
- Matching PlaceboPhase 2 · NCT03762395 · NCT03885245 · NCT05667701
- Metformin hydrochloride extended-release tabletsPhase 2 · NCT06273072
- MethylprednisolonePhase 2 · NCT07455396
- MG-ZG122 Humanized Monoclonal Antibody InjectionPhase 2 · NCT07054034
- Nebulized ketamine (0.5 mg/kg in normal saline to a total volume of 5ml) plus standard asthma excaerbationcarePhase 2 · NCT07112456
- OmalizumabPhase 2 · NCT07342803 · NCT05332067 · NCT02570984
- PA9159 Metered-Dose Inhaler, 120 μg per day for 28 daysPhase 2 · NCT07324707 · NCT07326995
- PA9159 Metered-Dose Inhaler, 240 μg per day for 28 daysPhase 2 · NCT07326995
- PA9159 Metered-Dose Inhaler, 60 μg per day for 28 daysPhase 2 · NCT07326995
- PF-07275315Phase 2 · NCT06977581
- povorcitinibPhase 2 · NCT05851443
- RademikibartPhase 2 · NCT07705737
- RC1416Phase 2 · NCT07403487
- RC1416 PlaceboPhase 2 · NCT07403487
- Research Grade RG-RVPhase 2 · NCT05331170
- ReslizumabPhase 2 · NCT02947945
- RSS0343 TabellaPhase 2 · NCT06775340
- Semaglutide Pen Injector 2.4mg weeklyPhase 2 · NCT05254314
- Short-Acting Beta Agonists (SABA)Phase 2 · NCT06676319
- SHR-1703 InjectionPhase 2 · NCT07701239 · NCT06441812
- SHR4597Phase 2 · NCT06940700
- Slow Release DHEAPhase 2 · NCT07179952
- Soy isoflavonePhase 2 · NCT05667701
- TozorakimabPhase 2 · NCT06932263
- VerekitugPhase 2 · NCT06966479
- Visually identical placebo Metformin hydrochloride extended-release tabletsPhase 2 · NCT06273072
- WIN378Phase 2 · NCT07120503
- Xenon-129 and Perfluoropropane (19F)Phase 2 · NCT02740868
- Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABAPhase 1/2 · NCT05111262
- ALUTARD SQ® Felis domesticusPhase 1/2 · NCT06960382
- BBT002Phase 1/2 · NCT07436949 · NCT06944925
- HB0056Phase 1/2 · NCT07899996
- PRA-216Phase 1/2 · NCT07245368
- RIG-101Phase 1/2 · NCT07488897
- Soy Isoflavone Nutritional SupplementsPhase 1/2 · NCT07828405
- Adenosine 5'-triphosphatePhase 1 · NCT07085975
- ADO-5030Phase 1 · NCT07281274
- AMG 691Phase 1 · NCT07745907 · NCT06637371
- Anakinra 100 Mg/0.67 Ml Inj SyringePhase 1 · NCT07600190
- APG777Phase 1 · NCT06920901
- ASY202Phase 1 · NCT07665892
- Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar LavagePhase 1 · NCT00595491
- CDX-622Phase 1 · NCT07330778
- CHF10136Phase 1 · NCT07851623
- CHF10136 matched placeboPhase 1 · NCT07851623
- CKD-706Phase 1 · NCT07358156
- cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cellsPhase 1 · NCT05147688
- EB070Phase 1 · NCT07886710
- EU-DupixentPhase 1 · NCT07358156
- GB-0895 (SC)Phase 1 · NCT07116889
- HXN-1013Phase 1 · NCT07900568
- Hyperpolarized Xe129Phase 1 · NCT04624490
- IBI3002Phase 1 · NCT07015749
- LipopolysaccharidesPhase 1 · NCT06270576
- MidazolamPhase 1 · NCT07660731
- PF-08103402Phase 1 · NCT07660731
- Salbutamol HFA-134aPhase 1 · NCT06433921
- Salbutamol HFA-152aPhase 1 · NCT06433921
- Saline Placebo/0.67 Ml Inj SyringePhase 1 · NCT07600190
- SKB575Phase 1 · NCT07732023
- US-DupixentPhase 1 · NCT07358156
- Yiqi Wenyang Sanhan Formula Combined with Acupoint ApplicationPhase 1 · NCT07540351
- Magnesium Sulfate within the first hourEarly phase 1 · NCT06137040
- Scalene Muscle Energy Technique (MET) + Respiratory PhysiotherapyEarly phase 1 · NCT07036887
- Vaginal seedingEarly phase 1 · NCT03567707
- whole lung allergen challengeEarly phase 1 · NCT01536522
Closest to patients
- Evaluation of Triple Therapy Using Magnetic Resonance Imaging in AsthmaEvaluation of Triple Therapy Using Magnetic Resonance Imaging in AsthmaRobarts Research Institute; The University of Western Ontario; London Health Sciences Centre · London, CanadaPhase 3Primary completion 2023
- Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe AsthmaOpening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe AsthmaDr. Andrew Thamboo, MD (sponsor)Phase 3Primary completion 2025
- Expertise Asthma COPD Program with Digital SupportExpertise Asthma COPD Program with Digital SupportFranciscus Gasthuis & Vlietland · Rotterdam, NetherlandsPhase 3Primary completion 2025
Let us optimize your content
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Publication
Association between serum magnesium status and bronchial asthma severity: a gender-matched retrospective cohort study.
Association between serum magnesium status and bronchial asthma severity: a gender-matched retrospective cohort study.
The Journal of asthma : official journal of the Association for the Care of Asthma
PubMed · PMID 42904461Publication
Therapeutic effect of quercetin on airway remodeling of ovalbumin-induced asthmatic mice via inhibition of the mtDNA-cGAS-STING pathway.
Therapeutic effect of quercetin on airway remodeling of ovalbumin-induced asthmatic mice via inhibition of the mtDNA-cGAS-STING pathway.
Molecular and cellular biochemistry
PubMed · PMID 42945014Publication
High-dose vitamin D3 supplementation in the prevention of viral-induced asthma in high-morbidity preschoolers (DIVA): a randomised controlled trial in Canada.
High-dose vitamin D3 supplementation in the prevention of viral-induced asthma in high-morbidity preschoolers (DIVA): a randomised controlled trial in Canada.
EClinicalMedicine
PubMed · PMID 42871976Publication
Study on the anti-asthmatic effect of Ginseng-Schisandra herb pair and its mechanisms in regulating the PI3K-AKT signaling pathway.
Study on the anti-asthmatic effect of Ginseng-Schisandra herb pair and its mechanisms in regulating the PI3K-AKT signaling pathway.
Journal of ginseng research
PubMed · PMID 42948188
Find fellow researchers
Groups with active Asthma work.
Harvard University
Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Inserm
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it
Brigham and Women's Hospital
Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Karolinska Institutet
Stockholm, Sweden
Team details appear once the team leader joins.
Is this your team? Claim it
King's College London
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Johns Hopkins University
Baltimore, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Manchester
Manchester, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
National Jewish Health
Denver, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Michigan
Ann Arbor, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University of Oxford
Oxford, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Icahn School of Medicine at Mount Sinai
New York, United States
Team details appear once the team leader joins.
Is this your team? Claim it